BEXIMCO PHARMA.GDR REGS 1 financial statements, including revenue, expenses, profit, and loss

The total revenue of R2WA for the last quarter is 92.38 M EUR, and it's 0.44% higher compared to the previous quarter. The net income of Q3 24 is 11.47 M EUR.